Suchergebnisse - Urania Dafni

Treffer weiter einschränken
  1. 1
    Breast Cancer Statistics in the European Union: Incidence and Survival across European Countries

    Breast Cancer Statistics in the European Union: Incidence and Survival across European Countries von Urania Dafni, Zoi Tsourti, Ioannis Alatsathianos

    Veröffentlicht 2019
    Volltext Volltext
    Revisão
    Zu den Favoriten
    Gespeichert in:
  2. 2
    Aetiology of fever in patients with acute stroke *

    Aetiology of fever in patients with acute stroke * von K. Georgilis, Androniki Plomaritoglou, Urania Dafni, Yiannis Bassiakos, Konstantinos Vemmos

    Veröffentlicht 1999
    Volltext Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  3. 3
    Blood Leptin and Adiponectin as Possible Mediators of the Relation Between Fat Mass and BMD in Perimenopausal Women

    Blood Leptin and Adiponectin as Possible Mediators of the Relation Between Fat Mass and BMD in Perimenopausal Women von Meropi Kontogianni, Urania Dafni, John G. Routsias, Fotini N. Skopouli

    Veröffentlicht 2004
    Volltext Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  4. 4
    Prevalence of Sjogren's syndrome in a closed rural community

    Prevalence of Sjogren's syndrome in a closed rural community von Urania Dafni, Athanasios G. Tzioufas, P. Staikos, Fotini N. Skopouli, Haralampos Μ. Moutsopoulos

    Veröffentlicht 1997
    Volltext Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  5. 5
    Dose-Ranging Study of Metronomic Oral Vinorelbine in Patients with Advanced Refractory Cancer

    Dose-Ranging Study of Metronomic Oral Vinorelbine in Patients with Advanced Refractory Cancer von Evangelos Briasoulis, Periklis Pappas, C. Puozzo, Christos Tolis, George Fountzilas, Urania Dafni, Μάριος Μαρσέλος, Nicholas Pavlidis

    Veröffentlicht 2009
    Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  6. 6
    VEGF pathway targeting agents, vessel normalization and tumor drug uptake: from bench to bedside

    VEGF pathway targeting agents, vessel normalization and tumor drug uptake: from bench to bedside von Marlous Arjaans, Carolina P. Schröder, Sjoukje F. Oosting, Urania Dafni, J.E. Kleibeuker, Elisabeth G.E. de Vries

    Veröffentlicht 2016
    Volltext Volltext
    Revisão
    Zu den Favoriten
    Gespeichert in:
  7. 7
    A standardised, generic, validated approach to stratify the magnitude of clinical benefit that can be anticipated from anti-cancer therapies: the European Society for Medical Oncology Magnitude of Clinical Benefit Scale (ESMO-MCBS)

    A standardised, generic, validated approach to stratify the magnitude of clinical benefit that can be anticipated from anti-cancer therapies: the European Society for Medical Oncol... von Nathan I. Cherny, Richard Sullivan, Urania Dafni, J. Martijn Kerst, Alberto Sobrero, Christoph Zielinski, Elisabeth G.E. de Vries, Martine Piccart

    Veröffentlicht 2015
    Volltext Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  8. 8
    Correcetions to “A standardised, generic, validated approach to stratify the magnitude of clinical benefit that can be anticipated from anti-cancer therapies: the European Society for Medical Oncology Magnitude of Clinical Benefit Scale (ESMO-MCBS)”

    Correcetions to “A standardised, generic, validated approach to stratify the magnitude of clinical benefit that can be anticipated from anti-cancer therapies: the European Society... von Nathan I. Cherny, Richard Sullivan, Urania Dafni, J. Martijn Kerst, A. Sobrero, C. Zielinski, Elisabeth G.E. de Vries, Martine Piccart

    Veröffentlicht 2016
    Volltext
    Errata/Corrigenda
    Zu den Favoriten
    Gespeichert in:
  9. 9
    Pulmonary Capillary Endothelium-Bound Angiotensin-Converting Enzyme Activity in Acute Lung Injury

    Pulmonary Capillary Endothelium-Bound Angiotensin-Converting Enzyme Activity in Acute Lung Injury von Stylianos E. Orfanos, Apostolos Armaganidis, Constantinos Glynos, Ekaterini Psevdi, Panagiotis Kaltsas, Paulina Sarafidou, John D. Catravas, Urania Dafni, David Langleben, Charis Roussos

    Veröffentlicht 2000
    Volltext Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  10. 10
    Effectiveness of PD-(L)1 inhibitors alone or in combination with platinum-doublet chemotherapy in first-line (1L) non-squamous non-small-cell lung cancer (Nsq-NSCLC) with PD-L1-high expression using real-world data

    Effectiveness of PD-(L)1 inhibitors alone or in combination with platinum-doublet chemotherapy in first-line (1L) non-squamous non-small-cell lung cancer (Nsq-NSCLC) with PD-L1-hig... von M. Pérol, Enriqueta Felip, Urania Dafni, Letizia Polito, Navdeep Pal, Zoi Tsourti, Thanh G.N. Ton, David M. Merritt, S. Morris, Rolf A. Stahel, Solange Peters

    Veröffentlicht 2022
    Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  11. 11
    Nuclear Localization of Signal Transducer and Activator of Transcription 3 in Head and Neck Squamous Cell Carcinoma Is Associated with a Better Prognosis

    Nuclear Localization of Signal Transducer and Activator of Transcription 3 in Head and Neck Squamous Cell Carcinoma Is Associated with a Better Prognosis von Eirini Pectasides, Ann-Marie Egloff, Clarence T. Sasaki, Panteleimon Kountourakis, Barbara Burtness, George Fountzilas, Urania Dafni, Thomas Zaramboukas, Θεόδωρος Ράμπιας, David L. Rimm, Jennifer R. Grandis, Amanda Psyrri

    Veröffentlicht 2010
    Volltext Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  12. 12
    Failure of Cytarabine in Progressive Multifocal Leukoencephalopathy Associated with Human Immunodeficiency Virus Infection

    Failure of Cytarabine in Progressive Multifocal Leukoencephalopathy Associated with Human Immunodeficiency Virus Infection von Colin D. Hall, Urania Dafni, David M. Simpson, David B. Clifford, Patricia E. Wetherill, Bruce A. Cohen, Justin McArthur, Harry Hollander, Constantin Yainnoutsos, Eugene O. Major, Linda Millar, Joseph Timpone

    Veröffentlicht 1998
    Volltext Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  13. 13
    Management of anastrozole-induced bone loss in breast cancer patients with oral risedronate: results from the ARBI prospective clinical trial

    Management of anastrozole-induced bone loss in breast cancer patients with oral risedronate: results from the ARBI prospective clinical trial von Christos Markopoulos, E. Tzoracoleftherakis, A. Polychronis, B. Venizelos, Urania Dafni, Grigorios Xepapadakis, J. Papadiamantis, Vasilios Zobolas, J. Misitzis, K. Kalogerakos, Angeliki Sarantopoulou, Gerasimos Siasos, Dimitrios Koukouras, Z. Antonopoulou, Spyros Lazarou, Helen Gogas

    Veröffentlicht 2010
    Volltext Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  14. 14
    Effects of Estrogen Receptor and Human Epidermal Growth Factor Receptor-2 Levels on the Efficacy of Trastuzumab

    Effects of Estrogen Receptor and Human Epidermal Growth Factor Receptor-2 Levels on the Efficacy of Trastuzumab von Sherene Loi, Urania Dafni, Dimitris Karlis, Varvara Polydoropoulou, Brandon Young, Scooter Willis, Bradley Long, Evandro de Azambuja, Christos Sotiriou, Giuseppe Viale, Josef Rüschoff, Martine Piccart, Mitch Dowsett, Stefan Michiels, Brian Leyland‐Jones

    Veröffentlicht 2016
    Volltext Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  15. 15
    Prognostic Significance of Autoimmunity during Treatment of Melanoma with Interferon

    Prognostic Significance of Autoimmunity during Treatment of Melanoma with Interferon von Helen Gogas, J. Ioannovich, Urania Dafni, Catherine Stavropoulou-Giokas, Konstantina Frangia, Dimosthenis Tsoutsos, P. Panagiotou, Aristidis Polyzos, O. Papadopoulos, Alexandros Stratigos, Christos Markopoulos, Dimitrios Bafaloukos, Dimitrios Pectasides, George Fountzilas, John M. Kirkwood

    Veröffentlicht 2006
    Volltext Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  16. 16
    Randomized phase II selection trial of FLASH and conventional radiotherapy for patients with localized cutaneous squamous cell carcinoma or basal cell carcinoma: A study protocol

    Randomized phase II selection trial of FLASH and conventional radiotherapy for patients with localized cutaneous squamous cell carcinoma or basal cell carcinoma: A study protocol von Rémy Kinj, Olivier Gaide, Wendy Jeanneret‐Sozzi, Urania Dafni, Stéphanie Viguet‐Carrin, Enea Sagittario, Magdalini Kypriotou, Julie Chenal, F. Duclos, Marine Hebeisen, Teresa Falco, Reiner Geyer, Patrik Gonçalves Jorge, Raphaël Moeckli, Jean Bourhis

    Veröffentlicht 2024
    Volltext Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  17. 17
    Afatinib in NSCLC With HER2 Mutations: Results of the Prospective, Open-Label Phase II NICHE Trial of European Thoracic Oncology Platform (ETOP)

    Afatinib in NSCLC With HER2 Mutations: Results of the Prospective, Open-Label Phase II NICHE Trial of European Thoracic Oncology Platform (ETOP) von Rafał Dziadziuszko, Egbert F. Smit, Urania Dafni, Juergen Wolf, Bartosz Wasąg, Wojciech Biernat, Stephen P. Finn, Roswitha Kammler, Zoi Tsourti, Manuela Rabaglio, Barbara Ruepp, Heidi Roschitzki‐Voser, Rolf A. Stahel, Enriqueta Felip, Solange Peters

    Veröffentlicht 2019
    Volltext Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  18. 18
    Randomized Phase III Study of 1 Month Versus 1 Year of Adjuvant High-Dose Interferon Alfa-2b in Patients With Resected High-Risk Melanoma

    Randomized Phase III Study of 1 Month Versus 1 Year of Adjuvant High-Dose Interferon Alfa-2b in Patients With Resected High-Risk Melanoma von Dimitrios Pectasides, Urania Dafni, Dimitrios Bafaloukos, Dimosthenis Skarlos, Aristidis Polyzos, Dimosthenis Tsoutsos, Haralabos P. Kalofonos, George Fountzilas, P. Panagiotou, George Kokkalis, Othon Papadopoulos, O Castana, Stefanos Papadopoulos, E. Stavrinidis, Georgia Vourli, J. Ioannovich, Helen Gogas

    Veröffentlicht 2009
    Volltext Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  19. 19
    Disease-Free Survival According to Degree of <i>HER2</i> Amplification for Patients Treated With Adjuvant Chemotherapy With or Without 1 Year of Trastuzumab: The HERA Trial

    Disease-Free Survival According to Degree of <i>HER2</i> Amplification for Patients Treated With Adjuvant Chemotherapy With or Without 1 Year of Trastuzumab: The HERA Trial von Mitch Dowsett, Marion Procter, Worta McCaskill‐Stevens, Evandro de Azambuja, Urania Dafni, Josef Rueschoff, Bruce W.M. Jordan, Stella Dolci, Mark Abramovitz, Oliver Stoß, Giuseppe Viale, Richard D. Gelber, Martine Piccart, Brian Leyland‐Jones

    Veröffentlicht 2009
    Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  20. 20
    A Phase I/II trial comparing autologous dendritic cell vaccine pulsed either with personalized peptides (PEP-DC) or with tumor lysate (OC-DC) in patients with advanced high-grade ovarian serous carcinoma

    A Phase I/II trial comparing autologous dendritic cell vaccine pulsed either with personalized peptides (PEP-DC) or with tumor lysate (OC-DC) in patients with advanced high-grade o... von Apostolos Sarivalasis, Caroline Boudousquié, Klara Balint, Brian J. Stevenson, Philippe O. Gannon, Emanuela M. Iancu, Laetitia Rossier, Silvia Martin Lluesma, Patrice Mathevet, Christine Sempoux, George Coukos, Urania Dafni, Alexandre Harari, Michal Bassani‐Sternberg, Lana E. Kandalaft

    Veröffentlicht 2019
    Volltext Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:

Suchwerkzeuge: